QITIAN Technology Group Co., Ltd.

SZSE:300061 Stock Report

Market Cap: CN¥8.4b

QITIAN Technology Group Past Earnings Performance

Past criteria checks 0/6

QITIAN Technology Group has been growing earnings at an average annual rate of 5.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 8.6% per year.

Key information

5.4%

Earnings growth rate

5.7%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate-8.6%
Return on equity-63.3%
Net Margin-61.1%
Next Earnings Update23 Apr 2025

Recent past performance updates

Recent updates

Some QITIAN Technology Group Co., Ltd. (SZSE:300061) Shareholders Look For Exit As Shares Take 31% Pounding

Nov 27
Some QITIAN Technology Group Co., Ltd. (SZSE:300061) Shareholders Look For Exit As Shares Take 31% Pounding

QITIAN Technology Group Co., Ltd. (SZSE:300061) Stock Rockets 103% As Investors Are Less Pessimistic Than Expected

Oct 01
QITIAN Technology Group Co., Ltd. (SZSE:300061) Stock Rockets 103% As Investors Are Less Pessimistic Than Expected

Optimistic Investors Push QITIAN Technology Group Co., Ltd. (SZSE:300061) Shares Up 35% But Growth Is Lacking

Jul 29
Optimistic Investors Push QITIAN Technology Group Co., Ltd. (SZSE:300061) Shares Up 35% But Growth Is Lacking

QITIAN Technology Group Co., Ltd.'s (SZSE:300061) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 07
QITIAN Technology Group Co., Ltd.'s (SZSE:300061) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Revenue & Expenses Breakdown

How QITIAN Technology Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300061 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24793-48422120
30 Jun 24891-49424420
31 Mar 24951-50326519
31 Dec 23975-49528222
30 Sep 231,048-3329726
30 Jun 231,097-430828
31 Mar 231,2424331330
01 Jan 231,2565230330
30 Sep 221,193-29130124
30 Jun 221,134-31231525
31 Mar 221,047-34033227
01 Jan 221,054-36637633
30 Sep 211,331-67048843
30 Jun 211,447-64154648
31 Mar 211,537-73561552
31 Dec 201,465-75063448
30 Sep 201,301-8568653
30 Jun 201,253-11064853
31 Mar 201,111-3563652
31 Dec 191,2335261252
30 Sep 191,600-98355456
30 Jun 191,887-85460858
31 Mar 192,196-76260171
31 Dec 182,305-79363178
30 Sep 182,17433763178
30 Jun 182,092290587112
31 Mar 182,00727060087
31 Dec 171,98729960770
30 Sep 171,80025256550
30 Jun 171,4801904830
31 Mar 171,2171543650
31 Dec 161,0011092700
30 Sep 16758601530
30 Jun 16734581510
31 Mar 16705551470
31 Dec 15694511360
30 Sep 15639441280
30 Jun 15633391290
31 Mar 15635391260
31 Dec 14621371200
30 Sep 14586391140
30 Jun 14535311010
31 Mar 1447223880

Quality Earnings: 300061 is currently unprofitable.

Growing Profit Margin: 300061 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300061 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.4% per year.

Accelerating Growth: Unable to compare 300061's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300061 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).


Return on Equity

High ROE: 300061 has a negative Return on Equity (-63.32%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 09:03
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

QITIAN Technology Group Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Junhao FanChina International Capital Corporation Limited
Kai ZhengChina Merchants Securities Co. Ltd.
Juan ShenHuatai Research